Cian Healthcare Limited's Resolution Plan Implementation Committee has approved a significant share capital restructuring following the National Company Law Tribunal's approval of the company's resolution plan under insolvency proceedings. The committee meeting held on January 23, 2026, addressed the reduction and cancellation of existing equity shares and subsequent allotment of fresh shares as mandated by the NCLT order dated December 18, 2025.

Share Capital Restructuring Details

The Implementation Committee approved a comprehensive restructuring of the company's equity shareholding structure in compliance with the NCLT-approved resolution plan submitted by Successful Resolution Applicant Mr. Pradeep Kumar Jain under the Insolvency and Bankruptcy Code, 2016.

Promoter Shareholding Cancellation

The existing equity shares held by erstwhile promoters will be completely cancelled without any consideration. The committee approved the reduction and extinguishment of 67,74,897 equity shares having face value of ₹10.00 each, representing 27.10% of the total existing paid-up equity shareholding. The estimated liquidation value of such equity shareholding has been regarded as nil, justifying the cancellation without consideration.

Public Shareholding Restructuring

The public shareholding will undergo significant reduction as part of the resolution plan implementation. The existing 1,82,20,867 equity shares held by public shareholders, representing 72.90% of total existing equity shareholding, will be reduced and cancelled. In lieu of this cancellation, 12,50,000 fresh equity shares with face value of ₹10.00 each will be allotted to public shareholders.

Fresh Share Allotment Process

The allotment of 12,50,000 fresh equity shares to public shareholders will be conducted proportionate to their equity shareholding in the erstwhile share capital as on the record date of January 21, 2026. The company will handle fractional share entitlements according to procedures outlined in the NCLT order and applicable laws.

Regulatory Compliance Framework

The restructuring process adheres to multiple regulatory requirements including Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, SEBI Master Circular dated November 11, 2024, and SEBI Circular dated December 31, 2024. The implementation also complies with relevant provisions of the Insolvency and Bankruptcy Code, 2016, and the specific NCLT order dated December 18, 2025.

The company has committed to keeping all stakeholders and regulatory authorities informed of further material developments regarding the resolution plan implementation. This restructuring represents a significant milestone in the company's corporate insolvency resolution process under the successful resolution applicant's approved plan.

Cian Healthcare Limited has revised the record date for the reduction, cancellation, and extinguishment of its existing paid-up share capital from January 16, 2026, to January 21, 2026. The revision was communicated to BSE Limited through a regulatory filing dated January 12, 2025, in compliance with Regulation 37 and 42 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

NCLT Order Implementation

The share capital restructuring follows an order from the Hon'ble National Company Law Tribunal, Mumbai, Bench-VI, dated December 18, 2025. The company's Resolution Plan Implementation Committee meeting held on January 09, 2026, resulted in the decision to revise the previously announced record date of January 16, 2026.

Share Capital Restructuring Details

The restructuring involves two distinct categories of shareholders with different treatment mechanisms:

Promoter Shareholding Extinguishment

The existing promoter shareholding of 67,74,897 equity shares, representing 27.10% of the total paid-up share capital, will be completely reduced, cancelled, and extinguished without any consideration. The estimated liquidation value of the promoter shareholding has been determined as nil, justifying the zero consideration approach.

Public Shareholder Treatment

Public shareholders holding 1,82,20,867 equity shares will have their existing holdings reduced and cancelled. However, they will receive 12,50,000 fresh equity shares with a face value of ₹10.00 each, issued in proportion to their shareholding as recorded on January 21, 2026.

Regulatory Compliance

The communication was signed by Roshen Chordiya, Chairman of the Resolution Plan Implementation Committee and former Resolution Professional of Cian Healthcare Limited. The filing ensures compliance with the Insolvency and Bankruptcy Code, 2016, alongside the SEBI listing regulations and the specific NCLT order provisions.